105 related articles for article (PubMed ID: 8370401)
1. Modification of the anti-CD3-induced cytokine release syndrome by anti-interferon-gamma or anti-interleukin-6 antibody treatment: protective effects and biphasic changes in blood cytokine levels.
Matthys P; Dillen C; Proost P; Heremans H; Van Damme J; Billiau A
Eur J Immunol; 1993 Sep; 23(9):2209-16. PubMed ID: 8370401
[TBL] [Abstract][Full Text] [Related]
2. IFN-gamma receptor-deficient mice are hypersensitive to the anti-CD3-induced cytokine release syndrome and thymocyte apoptosis. Protective role of endogenous nitric oxide.
Matthys P; Froyen G; Verdot L; Huang S; Sobis H; Van Damme J; Vray B; Aguet M; Billiau A
J Immunol; 1995 Oct; 155(8):3823-9. PubMed ID: 7561088
[TBL] [Abstract][Full Text] [Related]
3. Cascade modulation by anti-tumor necrosis factor monoclonal antibody of interferon-gamma, interleukin 3 and interleukin 6 release after triggering of the CD3/T cell receptor activation pathway.
Ferran C; Dy M; Sheehan K; Schreiber R; Grau G; Bluestone J; Bach JF; Chatenoud L
Eur J Immunol; 1991 Oct; 21(10):2349-53. PubMed ID: 1833202
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the release of cytokines and reduction of the shock syndrome induced by anti-CD3 monoclonal antibody in mice by interleukin-10.
Donckier V; Flament V; Gérard C; Abramowicz D; Vandenabeele P; Wissing M; Delvaux A; Fiers W; Leo O; Velu T
Transplantation; 1994 May; 57(10):1436-9. PubMed ID: 8197603
[TBL] [Abstract][Full Text] [Related]
5. In vivo T cell activation by anti-CD3 monoclonal antibody induces soluble TNF receptor release in mice. Effects of pentoxifylline, methylprednisolone, anti-TNF, and anti-IFN-gamma antibodies.
Bemelmans MH; Abramowicz D; Gouma DJ; Goldman M; Buurman WA
J Immunol; 1994 Jul; 153(2):499-506. PubMed ID: 8021491
[TBL] [Abstract][Full Text] [Related]
6. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis.
Mizuhara H; Uno M; Seki N; Yamashita M; Yamaoka M; Ogawa T; Kaneda K; Fujii T; Senoh H; Fujiwara H
Hepatology; 1996 Jun; 23(6):1608-15. PubMed ID: 8675184
[TBL] [Abstract][Full Text] [Related]
7. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease.
Szebeni J; Wang MG; Pearson DA; Szot GL; Sykes M
Transplantation; 1994 Dec; 58(12):1385-93. PubMed ID: 7809932
[TBL] [Abstract][Full Text] [Related]
8. Fas cross-linking mimics the inhibitory effect of anti-CD3 on IL-3-induced histamine and cytokine production by murine myeloid spleen cell precursors.
Ben Amor A; Schneider E; Arnould A; Machavoine F; Dy M
Exp Hematol; 1998 Aug; 26(9):903-9. PubMed ID: 9694512
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia.
Marchant A; Bruyns C; Vandenabeele P; Ducarme M; Gérard C; Delvaux A; De Groote D; Abramowicz D; Velu T; Goldman M
Eur J Immunol; 1994 May; 24(5):1167-71. PubMed ID: 8181527
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo.
Ferran C; Dautry F; Mérite S; Sheehan K; Schreiber R; Grau G; Bach JF; Chatenoud L
J Clin Invest; 1994 May; 93(5):2189-96. PubMed ID: 8182150
[TBL] [Abstract][Full Text] [Related]
11. [TH1 response in the experimental infection with Trypanosoma cruzi].
Cardoni RL; Antúnez MI; Abrami AA
Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
[TBL] [Abstract][Full Text] [Related]
12. The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer.
Mattner F; Fischer S; Guckes S; Jin S; Kaulen H; Schmitt E; Rüde E; Germann T
Eur J Immunol; 1993 Sep; 23(9):2202-8. PubMed ID: 8103745
[TBL] [Abstract][Full Text] [Related]
13. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production.
Yoshimoto T; Takeda K; Tanaka T; Ohkusu K; Kashiwamura S; Okamura H; Akira S; Nakanishi K
J Immunol; 1998 Oct; 161(7):3400-7. PubMed ID: 9759857
[TBL] [Abstract][Full Text] [Related]
14. Contact sensitization to oxazolone: involvement of both interferon-gamma and interleukin-4 in oxazolone-specific Ig and T-cell responses.
Thomson JA; Troutt AB; Kelso A
Immunology; 1993 Feb; 78(2):185-92. PubMed ID: 8473011
[TBL] [Abstract][Full Text] [Related]
15. An anti-murine CD3 monoclonal antibody with a low affinity for Fc gamma receptors suppresses transplantation responses while minimizing acute toxicity and immunogenicity.
Alegre ML; Tso JY; Sattar HA; Smith J; Desalle F; Cole M; Bluestone JA
J Immunol; 1995 Aug; 155(3):1544-55. PubMed ID: 7636216
[TBL] [Abstract][Full Text] [Related]
16. Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activation.
Ferran C; Sheehan K; Dy M; Schreiber R; Merite S; Landais P; Noel LH; Grau G; Bluestone J; Bach JF
Eur J Immunol; 1990 Mar; 20(3):509-15. PubMed ID: 2138557
[TBL] [Abstract][Full Text] [Related]
17. Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha.
Doherty GM; Lange JR; Langstein HN; Alexander HR; Buresh CM; Norton JA
J Immunol; 1992 Sep; 149(5):1666-70. PubMed ID: 1506688
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice.
Wysocka M; Kubin M; Vieira LQ; Ozmen L; Garotta G; Scott P; Trinchieri G
Eur J Immunol; 1995 Mar; 25(3):672-6. PubMed ID: 7705395
[TBL] [Abstract][Full Text] [Related]
19. Hypothermia and hypoglycemia induced by anti-CD3 monoclonal antibody in mice: role of tumor necrosis factor.
Alegre M; Vandenabeele P; Flamand V; Moser M; Leo O; Abramowicz D; Urbain J; Fiers W; Goldman M
Eur J Immunol; 1990 Mar; 20(3):707-10. PubMed ID: 2138564
[TBL] [Abstract][Full Text] [Related]
20. Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice.
Campbell IL; Kay TW; Oxbrow L; Harrison LC
J Clin Invest; 1991 Feb; 87(2):739-42. PubMed ID: 1899431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
